HC Wainwright restated their buy rating on shares of Greenwich LifeSciences (NASDAQ:GLSI – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $36.00 price objective on the stock. HC Wainwright also issued estimates for Greenwich LifeSciences’ Q4 2024 earnings at ($0.17) EPS, FY2024 earnings at ($0.75) EPS, […]
GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 .
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was acquired at an average cost of $19.08 per share, with a total value of $57,240.00. Following the purchase, the chief executive officer now owns 5,350,777 shares of […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel purchased 3,000 shares of the stock in a transaction dated Monday, April 1st. The stock was acquired at an average cost of $19.08 per share, for a total transaction of $57,240.00. Following the completion of the transaction, the chief executive officer now owns 5,350,777 […]